低分子肝素预防子痫前期的作用机制及靶点

Mechanism and targets of low molecular heparin in the prevention of preeclampsia

子痫前期是妊娠期特有的疾病,是全球孕产妇和围生期死亡的主要原因之一。本文通过查阅文献,综合分析低分子肝素(LMWH)在子痫前期预防和治疗中的作用及对妊娠结局的影响,为进一步研究和开发治疗子痫前期的药物提供新思路。结果发现,LMWH可能成为治疗子痫前期的新药物,可为子痫前期患者提供更有效和安全的治疗选择,促进母婴健康。

A comprehensive review of the literature was conducted to analyze the exact role of low molec-ular heparin(LMWH)in the prevention and treatment of preeclampsia,as well as its effect on pregnancy out-comes.This review aims to offer novel insights for further research and development of therapeutic agents for preeclampsia.The findings suggest that LMWH could emerge as a promising therapeutic agent for preeclampsia,providing a potentially more effective and safe treatment option for patients.This,in turn,could significantly en-hance the well-being of mothers and infants.